Healthequity vs P3 Health Partners
Healthequity and P3 Health Partners are similar in size: $1.31bn and $1.46bn of revenue in their latest fiscal years. Healthequity grew faster (9.5% against -2.8%). Healthequity kept more of each dollar of sales as profit: a net margin of 16.4% against -10.1%.
| Latest fiscal year | HealthequityHQY, 2026 | P3 Health PartnersPIII, 2025 |
|---|---|---|
| Revenue | $1.31bn | $1.46bn |
| Revenue growth | 9.5% | -2.8% |
| Net income | $215m | −$148m |
| Operating margin | 24.6% | — |
| Net margin | 16.4% | -10.1% |
| Return on equity | 10.2% | — |
| Free cash flow | $455m | −$91.2m |
| Cash | $319m | $25.0m |
| Total debt | $957m | $337m |
| Debt to equity | 45.4% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $299m | — |
| Employees | 2,814 | 320 |
| Market value | $8.52bn | $13.2m |
| Price vs our value range | Within our value range | — |
| Moat score | 64 (Moderate) | — |
| Insider trades, 12 months | 2 buys, 13 sales | 0 buys, 3 sales |